NEMAR copy of ds007864
You're viewing the NEMAR copy at v1.0.0.
Each OpenNeuro pull is a NEMAR major bump
(vN.0.0); intermediate versions are NEMAR-side fixes.
Neuroepo multisession Phase II and III
A randomized, placebo-controlled clinical trial investigating the neuroprotective and neuromodulatory effects of intranasal NeuroEPO (erythropoietin) in Parkinson's disease patients. The dataset comprises multisession EEG recordings and clinical assessments collected at baseline and 9-month post-intervention timepoints, with the goal of examining whether NeuroEPO-related cognitive and motor effects are mediated by changes in EEG source activity. This Phase II/III study provides evidence for functional brain reorganization mechanisms underlying EPO treatment in neurodegenerative disease.
AI-generated description, may include mistakesLoading demographics…
Coming soon. Per-file data-quality summaries are precomputed by the NEMAR processing pipeline. The static aggregate is on the way — tracked at nemar-cli#511.